Post-marketing Clinical Follow-up for Long-term Use of Intranasal Kinetic Oscillation in Subjects With Chronic Migraine

Exclusion Criteria

• •1. Unable to distinguish between migraine headache and other headache types;
• •2. An ongoing upper respiratory infection, nasal tumors, or wounds in the nasal cavity.
• •3. Nasal cavity abnormalities that prevents catheter insertion.
• •4. A concomitant condition that could cause excessive nose bleeding or ongoing treatment with anticoagulant medication (except Aspirin and Clopidogrel).
• •5. A known allergy to polyurethane (polyurethane is used in the catheter balloon).
• •6. Systemic diseases with manifestations in the nose.
• •7. Previous treatment with radiation therapy to the nasal area.
• •8. Nasal surgery performed within the last six months.
• •9. Concurrent condition or risk of non-compliance that, in the investigator's opinion, may affect the interpretation of performance or safety data or which otherwise contraindicates participation in a clinical investigation;
• •10. Pregnant and lactating women;
• •11. Participation in a clinical investigation within 3 months of enrolment or planned participation at any time during this clinical investigation;
• •12. Previous participation in this study;
• •13. Employees of the study site or the sponsor directly involved with the conduct of the study, or immediate family members of any such individuals.
• •Only at baseline visit (day 0) If subject missed \>4 days of eDiary entry, subject will be withdrawn.